Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vetnostrum Animal Health CoTPE:6936 -0.77%68 EV-to-EBIT is 9.48 as of Aug. 19, 2026, which is 40% below its 10-year median of 15.80. GuruFocus rates TPE:6936 with a GF Score™ of 68/100 and a GF Value™ of NT$39.86 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 1,561 Consumer Packaged Goods companies, Vetnostrum Animal Health Co ranks better than 54.26% on this metric.
Vetnostrum Animal Health Co (TPE:6936) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Vetnostrum Animal Health Co's Enterprise Value for the quarter that ended in Jun. 2026 was NT$1,946 Mil.
Vetnostrum Animal Health Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$200 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vetnostrum Animal Health Co EV-to-EBIT Related Terms
Vetnostrum Animal Health Co EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Farm Products subindustry, Vetnostrum Animal Health Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vetnostrum Animal Health Co EV-to-EBIT vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Vetnostrum Animal Health Co's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Vetnostrum Animal Health Co's EV-to-EBIT falls into.
Vetnostrum Animal Health Co's current Enterprise Value is NT$1,899 Mil.
Vetnostrum Animal Health Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$200 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vetnostrum Animal Health Co (TPE:6936) has a EV-to-EBIT of 9.48 as of Aug. 19, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Vetnostrum Animal Health Co and its competitors. This is 40% below median its historical median of 15.80. Over the past decade, Vetnostrum Animal Health Co's EV-to-EBIT has ranged from 9.38 to 77.92. According to the industry distribution chart, Vetnostrum Animal Health Co ranks #714 out of 1561 companies in the Consumer Packaged Goods industry, placing it in the top 45.7%.
Is Vetnostrum Animal Health Co's EV-to-EBIT too high?
Vetnostrum Animal Health Co's current EV-to-EBIT of 9.48 is 40% below median its 10-year median of 15.80. Over the past 10 years, this metric has ranged from a low of 9.38 to a high of 77.92. The Consumer Packaged Goods industry median EV-to-EBIT is 12.20. Vetnostrum Animal Health Co's value of 9.48 is 22.3% below this industry median. Based on the distribution chart, Vetnostrum Animal Health Co ranks #714 out of 1561 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Vetnostrum Animal Health Co has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vetnostrum Animal Health Co's EV-to-EBIT compare to ADM and BG?
According to the Consumer Packaged Goods industry distribution chart, Vetnostrum Animal Health Co ranks #714 out of 1561 companies for EV-to-EBIT. This puts Vetnostrum Animal Health Co in the upper half of its industry. The industry median EV-to-EBIT is 12.20. Vetnostrum Animal Health Co's value of 9.48 is 22.3% below this benchmark. Historically, Vetnostrum Animal Health Co's own EV-to-EBIT has ranged from 9.38 to 77.92 over the past decade. While the company's 10-year median is 15.80 vs. the industry median of 12.20, Vetnostrum Animal Health Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Consumer Packaged Goods company?
The median EV-to-EBIT among Consumer Packaged Goods companies is 12.20, based on 1,561 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vetnostrum Animal Health Co's current EV-to-EBIT of 9.48 is 22.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Vetnostrum Animal Health Co and its competitors. For the Consumer Packaged Goods industry, the median EV-to-EBIT is 12.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vetnostrum Animal Health Co's current EV-to-EBIT is 9.48, which is 40% below median its own 10-year median of 15.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vetnostrum Animal Health Co stock overvalued right now?
Based on GuruFocus' analysis, Vetnostrum Animal Health Co (TPE:6936) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$39.86, compared to a current price of NT$32.10 — trading 19.5% below its estimated fair value. The current EV-to-EBIT is 9.48, which is 40% below median its 10-year median of 15.80 and 22.3% below the Consumer Packaged Goods industry median of 12.20. Vetnostrum Animal Health Co's overall GF Score™ is 68/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Vetnostrum Animal Health Co (TPE:6936), the current EV-to-EBIT is 9.48 as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vetnostrum Animal Health Co (TPE:6936) Overvalued in 2026?
Based on GuruFocus' analysis, Vetnostrum Animal Health Co stock appears to be undervalued.
The current stock price of NT$32.10 is trading 19.5% below its estimated GF Value™ of NT$39.86.
GuruFocus considers Vetnostrum Animal Health Co to be Modestly Undervalued.
Key valuation signals for TPE:6936:
EV-to-EBIT: 9.48 (40% below median its 10-year median of 15.80)
GF Value™: NT$39.86 vs. price of NT$32.10 (19.5% below fair value)
Industry Position: 22.3% below the Consumer Packaged Goods median (#714 of 1561)
No single metric tells the full story. See the TPE:6936 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vetnostrum Animal Health Co Ltd is mainly engaged in importing, manufacturing, and selling pharmaceuticals and nutrition supplements for animals, feed additives, and feed. It derives a majority of its revenue from the sale of animal pharmaceuticals, medicated feed additives, and feeds and the rendering of drug testing services. Geographically, the company derives maximum revenue from Taiwan, followed by the USA, Malaysia, and other countries.
68GF Score
Get the complete analysis for TPE:6936
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6936 has been successfully added to your 
